Answers are grounded in this paper and cite their sources.
Pilot study shows ctDNA analysis may improve early detection of recurrence in Uveal Melanoma, suggesting further systematic review needed.
Serial ctDNA analysis may serve as a noninvasive tool for early detection of recurrence in UM. Co-occurrence of GNAQ, GNAS, and IDH1 mutations may represent a molecular signature of recurrence. Further validation in larger cohorts is needed to define optimal gene panels and VAF thresholds for clinical use.
No takes yet. Share an insight, caveat, or question.
Azimi et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: